Last reviewed · How we verify
Standardized Spinal Mixture
A standardized mixture formulation designed for spinal administration to deliver therapeutic agents directly to the spinal cord or cerebrospinal fluid.
A standardized mixture formulation designed for spinal administration to deliver therapeutic agents directly to the spinal cord or cerebrospinal fluid. Used for Spinal cord conditions (specific indications not publicly detailed).
At a glance
| Generic name | Standardized Spinal Mixture |
|---|---|
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Modality | Small molecule |
| Therapeutic area | Neurology |
| Phase | FDA-approved |
Mechanism of action
Standardized Spinal Mixture is a compounded pharmaceutical preparation intended for intrathecal or epidural delivery to the spinal region. The exact composition and mechanism depend on the specific active ingredients included in the formulation, which may vary based on clinical indication. Direct spinal delivery allows for localized therapeutic effects while potentially reducing systemic exposure.
Approved indications
- Spinal cord conditions (specific indications not publicly detailed)
Common side effects
- Headache
- Back pain
- Infection risk (intrathecal administration)
Key clinical trials
- Intrathecal Dexmedetomidine vs Epinephrine (PHASE4)
- Different Anesthesia Methods on Development of Postnatal Depression After Cesarean Delivery (NA)
- Spinal Anesthesia Versus Erector Spina Plane Block (NA)
- Local or Regional or General Anesthesia for Hernia Repair: a Randomized Controlled Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |